PTV margin analysis for radiotherapy tumor boosting in rectal cancer using BioXmark liquid fiducials

被引：0
|
作者：
Willems, Y. [1 ]
Canters, R. [1 ]
Timans, L. [1 ]
Opbroek, T. [1 ]
Verhaegen, F. [1 ]
Van Limbergen, E. [1 ]
Berbee, M. [1 ]
机构：
[1] Maastro, Radiat Oncol, Maastricht, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2022年 / 170卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1665
引用
收藏
页码：S1463 / S1464
页数：2
相关论文
共 50 条
  • [1] BioXmark liquid fiducials to enable radiotherapy tumor boosting in rectal cancer feasibility trial
    Berbee, M.
    Opbroek, T.
    Paulissen, J.
    Houben, R.
    Van Limbergen, E.
    Ta, B.
    Steenbakkers, I.
    Verhaegen, F.
    De Ridder, R.
    Jansen, R.
    Melenhorst, J.
    Bakers, F.
    Grabsch, H.
    Buijsen, J.
    Canters, R.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S1000 - S1001
  • [2] BioXmark® liquid fiducials to enable radiotherapy tumor boosting in rectal cancer, a feasibility trial
    Opbroek, Thirza J. S.
    Willems, Yves C. P.
    Verhaegen, Frank
    de Ridder, Rogier
    Hoge, Chantal
    Melenhorst, Jarno
    Bakers, Frans
    Grabsch, Heike, I
    Buijsen, Jeroen
    Van Limbergen, Evert J.
    Canters, Richard A. M.
    Berbee, Maaike
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2023, 38 : 90 - 95
  • [3] A Novel Method of Optimising the CTV to PTV Margin in Prostate Radiotherapy using Fiducials and Strict Organ Filling
    Conibear, J.
    Shoffren, O.
    Wells, P.
    Tipples, K.
    Dean, C.
    CLINICAL ONCOLOGY, 2015, 27 (03) : E4 - E4
  • [4] Margin and PTV volume reduction using a population based library of plans strategy for rectal cancer radiotherapy
    Beekman, Chris
    van Triest, Baukelien
    van Beek, Suzanne
    Sonke, Jan-Jakob
    Remeijer, Peter
    MEDICAL PHYSICS, 2018, 45 (10) : 4345 - 4354
  • [5] Online dose adaptation based on accumulated dose with zero PTV margin in rectal cancer radiotherapy
    Schroder, Lukas
    Wiersema, Lisa
    Betgen, Anja
    Marijnen, Corrie
    van der Heide, Uulke
    Sonke, Jan-Jakob
    van der Bijl, Erik
    Janssen, Tomas
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S4268 - S4270
  • [6] Feasibility of PTV margin reduction with online adaptive MR-guided radiotherapy for rectal cancer
    Eijkelenkamp, H.
    Van Zijp, L.
    Tijssen, R.
    Intven, M.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S910 - S911
  • [7] Decreased PTV margin with hypofractionated radiotherapy for prostate cancer
    Nature Clinical Practice Oncology, 2005, 2 (8): : 380 - 380
  • [8] Decreased PTV margin with hypofractionated radiotherapy for prostate cancer
    Nature Clinical Practice Urology, 2005, 2 (8): : 363 - 363
  • [9] Impact of PTV margin reduction on organ at risk dose in short course radiotherapy of rectal cancer.
    Devlin, L.
    O'Cathail, S.
    Grocutt, L.
    Duffton, A.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1668 - S1669
  • [10] PTV margin required for radiotherapy of prostate cancer on an MR linac
    Christiansen, R. L.
    Dysager, L.
    Hansen, O.
    Brink, C.
    Bernchou, U.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1284 - S1284
12345